Robert Cutler
General Counsel at TELESIS BIO, INC.
Net worth: 11 465 $ as of 2024-04-29
Profile
Robert H.
Cutler is currently the Chief Legal Officer at Telesis Bio, Inc. He previously worked as the Secretary & General Counsel at LifeVantage Corp.
from 2012 to 2015, Vice President-Business Development at Somaxon Pharmaceuticals, Inc., General Counsel at Viridos, Inc. from 2016 to 2021, and Corporate Officer at Brobeck, Phleger & Harrison LLP from 1999 to 2001.
Cutler received his undergraduate degree from the University of Utah and his graduate degree from Brigham Young University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TELESIS BIO, INC.
0.12% | 2024-02-29 | 35,718 ( 0.12% ) | 11 465 $ | 2024-04-29 |
Robert Cutler active positions
| Companies | Position | Start |
|---|---|---|
| TELESIS BIO, INC. | General Counsel | 2021-07-31 |
Former positions of Robert Cutler
| Companies | Position | End |
|---|---|---|
Viridos, Inc.
 Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | General Counsel | 2020-12-31 |
| LIFEVANTAGE CORPORATION | Investor Relations Contact | 2015-05-07 |
| Brobeck, Phleger & Harrison LLP | Corporate Officer/Principal | 2001-06-30 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Corporate Officer/Principal | - |
Training of Robert Cutler
| University of Utah | Undergraduate Degree |
| Brigham Young University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| TELESIS BIO, INC. | Commercial Services |
| Private companies | 3 |
|---|---|
| Brobeck, Phleger & Harrison LLP | Commercial Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Health Technology |
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Commercial Services |
- Stock Market
- Insiders
- Robert Cutler
